國立虎尾科技大學 |

Prudent Use of Antimicrobials on Dairy Farms : = Alternative Protocols for the Treatment or Prevention of Mastitis and Associated Outcomes.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Prudent Use of Antimicrobials on Dairy Farms :/
其他題名:	Alternative Protocols for the Treatment or Prevention of Mastitis and Associated Outcomes.
作者:	Vasquez, Amy Kristin.
面頁冊數:	1 online resource (280 pages)
附註:	Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B.
Contained By:	Dissertation Abstracts International79-10B(E).
標題:	Epidemiology. -
電子資源:	click for full text (PQDT)
ISBN:	9780438027008

Prudent Use of Antimicrobials on Dairy Farms : = Alternative Protocols for the Treatment or Prevention of Mastitis and Associated Outcomes.
Vasquez, Amy Kristin.

Prudent Use of Antimicrobials on Dairy Farms :Alternative Protocols for the Treatment or Prevention of Mastitis and Associated Outcomes. - 1 online resource (280 pages)

Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B.

Thesis (Ph.D.)--Cornell University, 2018.

Includes bibliographical references

Implementation of protocols for prudent use of antimicrobials on dairies results in economic returns, sustainability of products, and addresses public health concerns such as resistance and residues. Two main areas of application are intramammary (IMM) treatment of clinical mastitis (CM) and dry-cow therapy, which account for 80% of antibiotic use on dairies. The objectives herein were to 1) evaluate if the antibiotic hetacillin fell within a margin of efficacy or "noninferiority" to the reference treatment, a critically important (to human medicine) third-generation cephalosporin, ceftiofur; 2) assess a protocol that selectively treats CM cases based on daily culture results; 3) determine if similar protocols can be effectively executed on moderate-sized dairies without daily access to a professional laboratory; 4) determine if the metagenomic profiles of CM cases highlight a missed opportunity for non-treated cases; and 5) evaluate a culture-independent selective dry-cow therapy (SDCT) protocol. Noninferiority of hetacillin was concluded for bacteriological and clinical cures, as well as for many secondary outcomes. Administration of hetacillin over ceftiofur decreased treatment pen time with no statistical differences in bacteriological, pathogen, or clinical cures; milk yield and linear score (LS) postevent; nor additional risk of culling or quarter-level mastitis after the event. Use of a selective pathogen-based protocol decreased milk withholding time with no statistical differences in days to clinical cure, milk yield, and LS postevent; nor additional odds of culling in the months following. When similar strategies were applied on 8 moderate-sized dairies using on-farm or 5 day/week diagnostics, irregularity of data recording was drastically improved and no negative changes were reported. Reductions in antimicrobial use ranged from 6.8% to 92.5% and economic savings amounted to $2,200 to $4,600/dairy/yr. 16S rRNA analysis validated that despite dysbacteriosis in the mammary gland, there was no pathogen profile that was associated with negative or positive health and production outcomes; missed opportunities were not apparent. Finally, application of a data-driven, SDCT protocol resulted in no statistical differences in new infection risk, milk production and LS, or additional odds of culling or mastitis over the periparturient period between selectively or blanket-treated low-risk cows. Using SDCT or pathogen-based protocols for the treatment and prevention of CM can reduce antibiotic use by up to 2/3.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9780438027008Subjects--Topical Terms:

635923
Epidemiology.
Index Terms--Genre/Form:

554714
Electronic books.

Prudent Use of Antimicrobials on Dairy Farms : = Alternative Protocols for the Treatment or Prevention of Mastitis and Associated Outcomes.
LDR:03847ntm a2200337Ki 4500 001 917462
005 20181012133446.5
006 m o u
007 cr mn||||a|a||
008 190606s2018 xx obm 000 0 eng d
020 $a 9780438027008
035 $a (MiAaPQ)AAI10816480
035 $a (MiAaPQ)cornellgrad:10837
035 $a AAI10816480
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Vasquez, Amy Kristin. $3 1191516
245 1 0 $a Prudent Use of Antimicrobials on Dairy Farms : $b Alternative Protocols for the Treatment or Prevention of Mastitis and Associated Outcomes.
264 0 $c 2018
300 $a 1 online resource (280 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B.
500 $a Adviser: Daryl V. Nydam.
502 $a Thesis (Ph.D.)--Cornell University, 2018.
504 $a Includes bibliographical references
520 $a Implementation of protocols for prudent use of antimicrobials on dairies results in economic returns, sustainability of products, and addresses public health concerns such as resistance and residues. Two main areas of application are intramammary (IMM) treatment of clinical mastitis (CM) and dry-cow therapy, which account for 80% of antibiotic use on dairies. The objectives herein were to 1) evaluate if the antibiotic hetacillin fell within a margin of efficacy or "noninferiority" to the reference treatment, a critically important (to human medicine) third-generation cephalosporin, ceftiofur; 2) assess a protocol that selectively treats CM cases based on daily culture results; 3) determine if similar protocols can be effectively executed on moderate-sized dairies without daily access to a professional laboratory; 4) determine if the metagenomic profiles of CM cases highlight a missed opportunity for non-treated cases; and 5) evaluate a culture-independent selective dry-cow therapy (SDCT) protocol. Noninferiority of hetacillin was concluded for bacteriological and clinical cures, as well as for many secondary outcomes. Administration of hetacillin over ceftiofur decreased treatment pen time with no statistical differences in bacteriological, pathogen, or clinical cures; milk yield and linear score (LS) postevent; nor additional risk of culling or quarter-level mastitis after the event. Use of a selective pathogen-based protocol decreased milk withholding time with no statistical differences in days to clinical cure, milk yield, and LS postevent; nor additional odds of culling in the months following. When similar strategies were applied on 8 moderate-sized dairies using on-farm or 5 day/week diagnostics, irregularity of data recording was drastically improved and no negative changes were reported. Reductions in antimicrobial use ranged from 6.8% to 92.5% and economic savings amounted to $2,200 to $4,600/dairy/yr. 16S rRNA analysis validated that despite dysbacteriosis in the mammary gland, there was no pathogen profile that was associated with negative or positive health and production outcomes; missed opportunities were not apparent. Finally, application of a data-driven, SDCT protocol resulted in no statistical differences in new infection risk, milk production and LS, or additional odds of culling or mastitis over the periparturient period between selectively or blanket-treated low-risk cows. Using SDCT or pathogen-based protocols for the treatment and prevention of CM can reduce antibiotic use by up to 2/3.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Epidemiology. $3 635923
650 4 $a Animal sciences. $3 1178863
655 7 $a Electronic books. $2 local $3 554714
690 $a 0766
690 $a 0475
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a Cornell University. $b Comparative Biomed Sciences. $3 1187013
773 0 $t Dissertation Abstracts International $g 79-10B(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10816480 $z click for full text (PQDT)